iShares Trust - iShares Biotechnology ETF
GB ˙ LSE ˙ US4642875565
131,05 $ ↓ -0,77 (-0,58%)
2023-12-18
AKTIENPREIS
SecurityGB:0JGB / iShares Trust - iShares Biotechnology ETF
InstitutionFirst Interstate Bank
Latest Disclosed Ownership41,082 shares
Latest Disclosed Value $ 6,936,695
First Interstate Bank reports 18.68% increase in ownership of 0JGB / iShares Trust - iShares Biotechnology ETF

On April 29, 2026 - First Interstate Bank filed a 13F-HR form disclosing ownership of 41,082 shares of iShares Trust - iShares Biotechnology ETF (GB:0JGB) valued at $6,936,695 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 29, 2026 disclosing 34,617 shares of iShares Trust - iShares Biotechnology ETF. This represents a change in shares of 18.68% during the quarter. The current value of the position is $5,383,796 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-04-29 2026-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 41,082 6,465 18.68 6,937 18.73 0.3710
2026-01-29 2025-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 34,617 -766 -2.16 5,842 14.37 0.3135
2025-10-29 2025-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 35,383 -971 -2.67 5,108 11.07 0.2820
2025-07-30 2025-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 36,354 -1,023 -2.74 4,599 -3.79 0.2702
2025-04-30 2025-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 37,377 -2,272 -5.73 4,781 -8.80 0.2854
2025-02-04 2024-12-31 13F ISHARES ISHARES BIOTECH 464287556 39,649 -442 -1.10 5,242 -10.21 0.3174
2024-10-29 2024-09-30 13F ISHARES ISHARES BIOTECH 464287556 40,091 -440 -1.09 5,837 4.93 0.3546
2024-08-07 2024-06-30 13F ISHARES ISHARES BIOTECH 464287556 40,531 -577 -1.40 5,563 -1.37 0.3695
2024-05-01 2024-03-31 13F ISHARES ISHARES BIOTECH 464287556 41,108 -1,320 -3.11 5,641 -2.13 0.3907
2024-01-30 2023-12-31 13F ISHARES ISHARES BIOTECH 464287556 42,428 -1,059 -2.44 5,764 8.37 0.4272
2023-10-31 2023-09-30 13F ISHARES ISHARES BIOTECH 464287556 43,487 -1,694 -3.75 5,318 -7.29 0.4582
2023-08-01 2023-06-30 13F ISHARES ISHARES BIOTECH 464287556 45,181 -141 -0.31 5,736 -2.00 0.4738
2023-05-02 2023-03-31 13F ISHARES ISHARES BIOTECH 464287556 45,322 830 1.87 5,854 116,960.00 0.4473
2023-01-30 2022-12-31 13F ISHARES ISHARES BIOTECH 464287556 44,492 129 0.29 6 -99.90 0.4314
2022-10-25 2022-09-30 13F ISHARES ISHARES BIOTECH 464287556 44,363 1,454 3.39 5,189 2.81 0.4183
2022-08-12 2022-06-30 13F ISHARES ISHARES BIOTECH 464287556 42,909 21 0.05 5,047 -9.70 0.3815
2022-05-06 2022-03-31 13F ISHARES ISHARES BIOTECH 464287556 42,888 42,888 5,589 0.4904
2022-05-06 2022-03-31 13F ISHARES ISHARES BIOTECH 464287556 51 7
2020-05-11 2020-03-31 13F ISHARES NASDAQ BIOTECH 464287556 0 -120 -100.00 0 -100.00
2020-02-06 2019-12-31 13F ISHARES NASDAQ BIOTECH 464287556 120 0 0.00 14 16.67 0.0031
2019-10-30 2019-09-30 13F ISHARES NASDAQ BIOTECH 464287556 120 0 0.00 12 -7.69 0.0028
2019-08-05 2019-06-30 13F ISHARES NASDAQ BIOTECH 464287556 120 0 0.00 13 0.00 0.0029
2019-05-02 2019-03-31 13F ISHARES NASDAQ BIOTECH 464287556 120 0 0.00 13 8.33 0.0029
2019-01-30 2018-12-31 13F ISHARES NASDAQ BIOTECH 464287556 120 0 0.00 12 -20.00 0.0030
2018-11-07 2018-09-30 13F ISHARES NASDAQ BIOTECH 464287556 120 0 0.00 15 15.38 0.0032
2018-07-26 2018-06-30 13F ISHARES NASDAQ BIOTECH 464287556 120 0 0.00 13 0.00 0.0029
2018-04-25 2018-03-31 13F ISHARES NASDAQ BIOTECH 464287556 120 0 0.00 13 0.00 0.0029
2018-02-13 2017-12-31 13F ISHARES NASDAQ BIOTECH 464287556 120 80 200.00 13 0.00 0.0028
2017-11-08 2017-09-30 13F ISHARES NASDQ BIOTEC ETF 464287556 40 0 0.00 13 8.33 0.0028
2017-08-07 2017-06-30 13F BlackRock Fund Advisors NASDQ BIOTEC ETF 464287556 40 0 0.00 12 0.00 0.0025
2017-05-11 2017-03-31 13F BlackRock Fund Advisors NASDQ BIOTEC ETF 464287556 40 0 0.00 12 9.09 0.0025
2017-01-31 2016-12-31 13F BlackRock Fund Advisors NASDQ BIOTEC ETF 464287556 40 0 0.00 11 -8.33 0.0022
2016-11-10 2016-09-30 13F BlackRock Fund Advisors NASDQ BIOTEC ETF 464287556 40 0 0.00 12 20.00 0.0025
2016-08-09 2016-06-30 13F iShares ETFs NASDQ BIOTEC ETF 464287556 40 0 0.00 10 0.00 0.0021
2016-05-11 2016-03-31 13F BlackRock Fund Advisors NASDQ BIOTEC ETF 464287556 40 0 0.00 10 -28.57 0.0021
2016-02-02 2015-12-31 13F iShares ETFs NASDQ BIOTEC ETF 464287556 40 0 0.00 14 16.67 0.0029
2015-11-10 2015-09-30 13F BlackRock Fund Advisors Other 464287556 40 40 12 0.0026
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.